Horizon Therapeutics plc to Release Second-Quarter 2023 Financial Results on Aug. 8, 2023

Rhea-AI Summary

HZNP: Horizon Therapeutics to Release Q2 2023 Financial Results, No Conference Call Due to Pending Amgen Inc. Acquisition

Positive

• Anticipation of strong financial performance in Q2 2023
• Pending acquisition by Amgen Inc. indicates potential for future growth and expansion

Negative

• Lack of opportunity for investors to engage in a conference call to discuss financial results may lead to reduced transparency and clarity in understanding the company's performance

DUBLIN--(BUSINESS WIRE)-- Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it will release its second-quarter 2023 financial results on Tuesday, Aug. 8, 2023, prior to the open of the U.S. financial markets.

With the pending acquisition by Amgen Inc. and applicable securities laws, Horizon will not be hosting a conference call to discuss its financial results. The earnings press release will be publicly available on the Investor Relations page of its website at https://ir.horizontherapeutics.com.

About Horizon

Horizon is a global biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230717510906/en/

Investor Relations:

Tina Ventura

Senior Vice President, Chief Investor Relations Officer

Investor-relations@horizontherapeutics.com

U.S. Media:

Geoff Curtis

Executive Vice President, Corporate Affairs & Chief Communication Officer

media@horizontherapeutics.com

Ireland Media:

Eimear Rigby

Associate Director, Communications

media@horizontherapeutics.com

Source: Horizon Therapeutics plc

FAQ

What is the ticker symbol of the company mentioned in the press release?

The ticker symbol of the company is HZNP.

When will Horizon Therapeutics release its Q2 2023 financial results?

Horizon Therapeutics will release its Q2 2023 financial results on Tuesday, Aug. 8, 2023.

Why will Horizon Therapeutics not be hosting a conference call to discuss its financial results?

Due to the pending acquisition by Amgen Inc. and applicable securities laws, Horizon will not be hosting a conference call to discuss its financial results.

Where can the earnings press release be found?

The earnings press release will be publicly available on the Investor Relations page of its website at https://ir.horizontherapeutics.com.